首页 › 基金 › OAKTREE CAPITAL MANAGEMENT LP › INDV
OAKTREE CAPITAL MANAGEMENT LP 对 INDV 的持仓历史
INDIVIOR PHARMACEUTICALS INC · 医疗保健
OAKTREE CAPITAL MANAGEMENT LP 在 Q2 2026 的 13F 申报中披露持有 INDV(INDIVIOR PHARMACEUTICALS INC)6,127,212 股,市值约 US$251.4M,约占其申报组合的 3.67%,在其申报持仓中市值排名第 7 位。 OAKTREE CAPITAL MANAGEMENT LP 最近 10 个申报季度中有 10 个季度披露了 INDV 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
OAKTREE CAPITAL MANAGEMENT LP 对 INDV 的持仓演变
OAKTREE CAPITAL MANAGEMENT LP 于 Q1 2024 首次披露 INDV 持仓:3,351,236 股(约 US$71.7M)。 该持仓在 Q4 2025 达到峰值 7,108,644 股,市值约 US$255.1M。 在 10 次申报中,OAKTREE CAPITAL MANAGEMENT LP 4 次增持、4 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 6,127,212 股、市值约 US$251.4M,环比减持 -856,890 股。。 持仓曾出现大幅变动:Q3 2024 增持约 112%、Q3 2025 增持约 2242% (随后一个季度股价上涨 49%)、Q4 2025 减持约 97% (随后一个季度股价下跌 15%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 3.35M | $71.71M | 新进 |
| Q2 2024 | 4.49M | $70.43M | 增持 |
| Q3 2024 | 9.52M | $94.07M | 增持 |
| Q4 2024 | 8.73M | $112.00M | 减持 |
| Q1 2025 | 11.01M | $103.45M | 增持 |
| Q2 2025 | 11.01M | $162.27M | 持有 |
| Q3 2025 | 257.79M | $10.69M | 增持 |
| Q4 2025 | 7.11M | $255.06M | 减持 |
| Q1 2026 | 6.98M | $212.88M | 减持 |
| Q2 2026 | 6.13M | $251.40M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 INDV 与 13F 数据
INDV(INDIVIOR PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 INDV,申报仓位最大的包括:Two Seas Capital LP (US$131.6M), Madison Avenue Partners, LP (US$117.9M), MANGROVE PARTNERS IM, LLC (US$109.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 INDV 的基金
- Two Seas Capital LP 3.67M 股 · $131.61M · Q3 2026
- Madison Avenue Partners, LP 2.87M 股 · $117.94M · Q2 2026
- MANGROVE PARTNERS IM, LLC 2.68M 股 · $109.83M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.65M 股 · $67.65M · Q2 2026
- Newtyn Management, LLC 1.31M 股 · $53.58M · Q2 2026
- GENDELL JEFFREY L 1.10M 股 · $44.98M · Q2 2026
- Soleus Capital Management, L.P. 1.06M 股 · $43.66M · Q2 2026
- Claret Asset Management Corp 685.52K 股 · $28.13M · Q2 2026
- Divisadero Street Capital Management, LP 601.86K 股 · $24.69M · Q2 2026
- Melqart Asset Management (UK) Ltd 585.66K 股 · $24.03M · Q2 2026
- Alta Fundamental Advisers LLC 404.53K 股 · $16.60M · Q2 2026
- PFM Health Sciences, LP 401.21K 股 · $16.46M · Q2 2026
更多关于 OAKTREE CAPITAL MANAGEMENT LP
常见问题
How long has OAKTREE CAPITAL MANAGEMENT LP held INDV?
OAKTREE CAPITAL MANAGEMENT LP has disclosed INDV holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is OAKTREE CAPITAL MANAGEMENT LP's current position in INDV?
As of Q2 2026, OAKTREE CAPITAL MANAGEMENT LP holds 6.13M shares of INDV (INDIVIOR PHARMACEUTICALS INC), valued at $251.40M, representing 3.67% of its reported portfolio and ranking #7.
Has OAKTREE CAPITAL MANAGEMENT LP been buying or selling INDV?
In the latest 13F filing (Q2 2026), OAKTREE CAPITAL MANAGEMENT LP reduced its position in INDV. The position peaked in Q4 2025 at 7.11M shares.
Which other funds hold INDV?
Other major institutional holders of INDV include Two Seas Capital LP, Madison Avenue Partners, LP, MANGROVE PARTNERS IM, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.